- No file added yet -

Effects of Ertugliflozin on Liver Enzymes in Patients with Type 2 Diabetes: A Post-Hoc Pooled Analysis of Phase 3 Trials

figure

posted on 2020-06-29, 09:57 authored by Silvina Gallo, Roberto A. Calle, Steven G. Terra, Annpey Pong, Lisa Tarasenko, Annaswamy Raji

The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).

History

Usage metrics

Keywords

Alanine aminotransferase Aspartate aminotransferase Body weight Ertugliflozin Fibrosis-4 index HbA1c Liver enzymes SGLT2 inhibitor Type 2 diabetes mellitus

Licence

CC BY-NC 4.0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM